期刊
EXPERIMENTAL BIOLOGY AND MEDICINE
卷 243, 期 4, 页码 370-374出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1535370218754492
关键词
Charcot-Marie-Tooth 1A (CMT1A); ErbB; Neuregulin1 (NRG1); neuropathy; peripheral nerve; Schwann cell
资金
- Federazione Italiana Sclerosi Multipla (FISM) [2015/R/17]
- Fondo per la Ricerca Locale (University of Torino)
Neuregulin1 (NRG1) is a growth factor playing a pivotal role in peripheral nerve development through the activation of the transmembrane co-receptors ErbB2-ErbB3. Soluble NRG1 isoforms, mainly secreted by Schwann cells, are strongly and transiently up-regulated after acute peripheral nerve injury, thus suggesting that they play a crucial role also in the response to nerve damage. Here we show that in the rat experimental model of the peripheral demyelinating neuropathy Charcot-Marie-Tooth 1A (CMT1A) the expression of the different NRG1 isoforms (soluble, type and , type alpha and beta) is strongly up-regulated, as well as the expression of NRG1 co-receptors ErbB2-ErbB3, thus showing that CMT1A nerves have a gene expression pattern highly reminiscent of injured nerves. Because it has been shown that high concentrations of soluble NRG1 negatively affect myelination, we suggest that soluble NRG1 over-expression might play a negative role in the pathogenesis of CMT1A disease, and that a therapeutic approach, aimed to interfere with NRG1 activity, might be beneficial for CMT1A patients. Further studies will be necessary to test this hypothesis in animal models and to evaluate NRG1 expression in human patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据